Regeneron Research Facility is a clinical research site located in Tarrytown, New York, United States 10591.
Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.
Regeneron Research Facility has participated in 2 clinical trials with 1 currently active.
Therapeutic areas: Relapsed and Refractory Multiple Myeloma (RRMM), Advanced Non-small Cell Lung Cancer.
Sponsors: Regeneron Pharmaceuticals.
Is this your site? Claim your profile and control the information sponsors and patients see.
Browse all research sites in New York · View every site in Tarrytown
Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Regeneron Research Facility has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Regeneron Research Facility has 2 clinical trials on record, with 1 currently active. Their work covers Relapsed and Refractory Multiple Myeloma (RRMM), Advanced Non-small Cell Lung Cancer.
Regeneron Research Facility has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.